Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
ESCC, Oesophageal Squamous Cell Carcinoma: Click to Expand ⟱
Esophageal cancer is a growth of cells that starts in the esophagus.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
ESCC, |
KYSE150 |
|
|
|
- |
in-vivo, |
ESCC, |
NA |
|
|
|
FAK↓, GlucoseCon↓, Casp3↑, Casp7↑, p‑Akt↓, TumCG↓, Weight∅,
*Inflam↓, TumCG↓, TumCP↓, TumCMig↓, TumCI↓, Apoptosis↓, TumCG↓, PI3K↓, p‑Akt↓, RAS↓, Raf↓, p‑ERK↓, Bcl-2↓, BAX↑,
| - |
in-vitro, |
ESCC, |
KYSE450 |
|
|
|
- |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
TumCG↓, TumCP↓, TumCMig↓, TumCI↓, angioG↓, Apoptosis↑, PI3K↓, Akt↓, p‑Akt↓, survivin↓, Bax:Bcl2↑, Casp3↑, Casp9↑, MMP2↓, MMP9↓, VEGF↓, EMT↓, eff↑, DNAdam↑, p‑STAT3↑, ChemoSen↑,
| - |
in-vitro, |
ESCC, |
KYSE-30 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE450 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑PARP1↑, cl‑Casp3↑, cl‑Casp9↑, PI3K↓, p‑Akt↓, p‑mTOR↓, PTEN↑,
| - |
vitro+vivo, |
ESCC, |
TE1 |
|
|
|
- |
vitro+vivo, |
ESCC, |
KYSE150 |
|
|
|
TumCP↓, TumCI↓, TumCMig↓, EMT↓, Apoptosis↑, RadioS↑, p‑STAT3↓, p‑Akt↓, p‑ERK↓,
| - |
vitro+vivo, |
ESCC, |
KYSE-510 |
|
|
|
- |
in-vitro, |
ESCC, |
KYSE450 |
|
|
|
TumCG↓, Apoptosis↓, Casp↑, Bcl-2↓, EMT↓, TumAuto↑, ROS↑, Akt↓, PI3K↓, Catalase↓, SOD1↓, SOD2↓, eff↓,
AMPK↑, EGFR↓, PDGFRA↓, PDGFRB↓, Akt↓, TumCG↓,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↓, 1, ROS↑, 1, SOD1↓, 1, SOD2↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
Raf↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, GlucoseCon↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 3, p‑Akt↓, 5, Apoptosis↓, 2, Apoptosis↑, 3, BAX↑, 2, Bax:Bcl2↑, 1, Bcl-2↓, 3, Casp↑, 1, Casp3↑, 2, cl‑Casp3↑, 1, Casp7↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, survivin↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, cl‑PARP1↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
EMT↓, 3, p‑ERK↓, 2, p‑mTOR↓, 1, PDGFRA↓, 1, PDGFRB↓, 1, PI3K↓, 4, PTEN↑, 1, RAS↓, 1, p‑STAT3↓, 1, p‑STAT3↑, 1, TumCG↓, 6,
Migration(tgid=13) ⓘ
FAK↓, 1, MMP2↓, 1, MMP9↓, 1, TumCI↓, 4, TumCMig↓, 4, TumCP↓, 4,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, EGFR↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, eff↓, 1, eff↑, 1, RadioS↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1,
Functional Outcomes(tgid=23) ⓘ
Weight∅, 1,
Total Targets: 50
Pathway results for Effect on Normal Cells:
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:41 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page